asiaone.com/business/prote… #ADA2018

.Proteomics-Int Revenue Up 27% To $1.2m, Loss Up 57% To $1.4m - subscribe to Biotech Daily biotechdaily.com.au

sbs.com.au/news/australia… #promarkerD #diabetes

Aussie test helps 30 million USA diabetic patients #AFR #AustralianFinancialReview #PromarkerD #diabetes

news.com.au/national/break… #promarkerD #diabetes #DKD

.Proteomics-Int Receives $834k Federal R&D Tax Incentive - subscribe to Biotech Daily biotechdaily.com.au

.Proteomics-Int Licences Promarkerd For Spain; Wins WA Gong - subscribe to Biotech Daily biotechdaily.com.au

proteomics.com.au/promarkerd-kit… @diabetestecsoc #2018DTM #diabetes #DKD #kidneydisease #PromarkerD

Announced at #2018DTM proteomics.com.au/promarkerd-kit…

In a world-first, #biotech company Proteomics-Int has discovered a predictive diagnostic test to help manage one of the complications of #diabetes and a leading cause of death — diabetic kidney disease (DKD). Read more: bit.ly/2XxEdSy

#promarkerD best in world featured in DDN ddn-news.com/index.php?news…

New biomarkers may accurately identify renal disease in type 2 diabetes patients - ow.ly/ZVYp30fSpAx ow.ly/P8va30fSpAy #DKD

Proteomics International Investing in CPR Pharma Services | GenomeWeb ow.ly/bFmL30inA6J

Pharma Letter BRIEF—Proteonomics buys stake in CPR Pharma ow.ly/1kRK30inA8S

Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services prwire.com.au/pr/75319/prote…

Proteomics International Announces Strategic Alliance and Investment in CPR Pharma Services | BioSpace ow.ly/dc3k30inApS

BRIEF-Proteomics International Laboratories Updates On Investment In CPR Pharma Services | Reuters ow.ly/FGqc30inAvC

Proteomics International Investing in CPR Pharma Services | 360Dx ow.ly/59ga30inAF4

.Proteomics-Int $3.4m March 31 Options Underwritten - subscribe to Biotech Daily biotechdaily.com.au